Current Pharmaceutical Biotechnology

Current Pharmaceutical Biotechnology 由 Bentham Science Publishers B.V. 出版，属中科院医学大类（2025 升级版4区）。按 OpenAlex 近年发文统计，该刊主要发表 RNA Interference and Gene Delivery、Monoclonal and Polyclonal Antibodies Research、Nanoparticle-Based Drug Delivery 等主题的论文，这 3 个主题约占 21.9%，主导子领域为 Molecular Biology。（根据 OpenAlex 主题统计与中科院分区数据生成）

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include: DNA/protein engineering and processing Synthetic biotechnology Omics (genomics, proteomics, metabolomics and systems biology) Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes) Drug delivery and targeting Nanobiotechnology Molecular pharmaceutics and molecular pharmacology Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes) Pharmacokinetics and pharmacodynamics Applied Microbiology Bioinformatics (computational biopharmaceutics and modeling) Environmental biotechnology Regenerative medicine (stem cells, tissue engineering and biomaterials) Translational immunology (cell therapies, antibody engineering, xenotransplantation) Industrial bioprocesses for drug production and development Biosafety Biotech ethics Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

来源：LetPub

研究方向（LetPub）：医学-生化与分子生物学

中科院期刊分区表

数据库收录

SCIEScopusLetPub

国际期刊预警名单：各版本均未列入LetPub

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

影响因子

2.76LetPub · 2026-09-13

CiteScore 2026-06

5.9LetPub · 2026-09-13

SJR 2026-06

0.61LetPub · 2026-09-13

SNIP 2026-06

0.63LetPub · 2026-09-13

h-index

73LetPub · 2026-09-13

h-index

114OpenAlex · 2026-10-01

i10-index

1,757OpenAlex · 2026-10-01

两年平均被引

2.89OpenAlex · 2026-10-01

自引率

6.9%LetPub · 2026-09-13

Gold OA 文章占比

1.38%LetPub · 2026-09-13

发文规模

年文章数

159LetPub · 2026-09-13

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

其他来源

平均审稿速度（社区反馈）

一般,3-6周LetPub · 2026-09-13

平均录用比例（社区反馈）

容易LetPub · 2026-09-13

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

尚未从任何来源获得费用信息，请以期刊官网为准。

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

出版商

Bentham Science Publishers B.V.

出版国家或地区

UNITED STATES

出版语言

English

出版周期

Bimonthly

创刊年份

2000

ISSN

1389-2010

电子版 ISSN

1873-4316

官方链接

• 期刊主页 ↗OpenAlex
• 投稿系统 ↗LetPub